Safety and environmental concerns have recently dictated the proper disposal of nitrilotriacetate (NTA). Biodegradation of NTA is initiated by NTA monooxygenase, which is composed of two proteins: component A and component B. The NTA monooxygenase component A protein from Corynebacterium glutamicum was crystallized using the sitting-drop vapour-diffusion method in the presence of ammonium sulfate as the precipitant. X-ray diffraction data were collected to a maximum resolution of 2.5 Å on a synchrotron beamline. The crystal belongs to the monoclinic space group C2, with unit-cell parameters a = 111.04, b = 98.51, c = 171.61 Å , = 101.94 . The asymmetric unit consists of four molecules, corresponding to a packing density of 2.3 Å 3 Da À1 . The structure was solved by molecular replacement. Structure refinement is in progress. # 2006 International Union of Crystallography All rights reserved
Introduction
The synthetic chelating agent nitrilotriacetate (NTA) has been widely used for various radionuclide-processing and decontamination procedures, such as textile, paper and pulp processing and water treatment. The extensive use of NTA has led to considerable concern about the potential of NTA to remobilize radionuclides and toxic heavy metals from soils and sediments (Anderson et al., 1985; Bucheli-Witschel & Egli, 2001) . Such undesirable environmental consequences would cause direct health problems or affect agricultural crops and livestock, with potential transfer of toxic substances to human beings through the food chain.
A number of NTA-degrading bacterial strains have been isolated and biochemical and genetic studies on NTA degradation are being pursued (Bucheli-Witschel & Egli, 2001; Egli, 2001) . NTA monooxygenase (NTA_MO) is an enzyme responsible for the oxidative cleavage of NTA to iminodiacetate (IDA) and glyoxylate. The enzyme catalyzes the hydroxylation of an -carbon of NTA, resulting in the spontaneous formation of IDA and glyoxylate (Firestone & Tiedje, 1978; Fig. 1) . NTA_MO activity requires a unique two-enzyme system composed of components A and B. Component A (NTA_MO_A) is a monooxygenase that oxidizes NTA at the expense of reduced flavin mononucleotide (FMNH 2 ) and O 2 , whereas component B is a reduced nicotinamide adenine dinucleotide (NADH):FMN oxidoreductase that provides FMNH 2 for NTA oxidization by using NADH to reduce FMN to FMNH 2 . Component B can be substituted by any enzyme that can provide reduced FMN, suggesting that NTA_MO_A plays the central role in NTA_MO biodegradation of NTA (Xu et al., 1997) .
To date, no structure-function study has been reported for NTA_MO_A, although a crystal structure of the Bacillus subtilis Ytnj protein annotated as NTA_MO_A has been deposited in the Protein Data Bank (PDB) with PDB code 1yw1. However, there are no published studies on the catalytic mechanism of Ytnj. As a step towards elucidating the enzyme mechanism of NTA_MO_A, we recently cloned its gene from Corynebacterium glutamicum ATCC 13032, purified it and assessed its ability to oxidize NTA using FMNH 2 generated by an NADH:FMN oxidoreductase (Roche Applied Science) from Photobacterium fischeri (unpublished results). We obtained crystals of the NTA_MO_A protein. The crystals diffracted well and data were collected to a resolution of 2.5 Å . Here, we describe the crystallization and initial X-ray crystallographic analysis of the NTA_MO_A protein.
Expression and purification of the recombinant NTA_MO component A protein
The gene encoding NTA_MO_A was amplified from C. glutamicum chromosomal DNA by the polymerase chain reaction (PCR) using the following primers: 5 0 -GCGCGCATATGACACCGAAAGAAA-TACACCTCAAC-3 0 and 5 0 -GCGCGCTCGAGTTAAACAAGTG-ACACCGGGCTGAATAAG-3 0 . The primers carried NdeI and XhoI restriction-enzyme sites at their 5 0 and 3 0 ends, respectively. The resulting PCR product was cloned into the pPosKJ expression vector (Kwon et al., 2005) , which resulted in the expression of NTA_MO_A fused to a hexahistidine tag and bacterial haemoglobin (6ÂHis-VHb) at its N-terminus. Escherichia coli B834 cells transformed with the resulting plasmid, termed pPosKJ:nta_mo_A, were then used to produce 6ÂHis-VHb-fused NTA_MO_A protein as follows. A 20 ml overnight culture was inoculated into 1 l of Luria-Bertani (LB) medium containing 100 mg ml À1 ampicillin, which was then incubated at 310 K. When the culture reached log phase (OD 600 = 0.6), expression of the 6ÂHis-VHb-fused protein was induced by adding isopropyl -d-thiogalactoside to a final concentration of 1 mM. The cells were grown for an additional 16 h at 293 K. Harvested cells, which were red in colour, were resuspended in buffer A (20 mM Tris-HCl pH 8.0, 5 mM -mercaptoethanol) and disrupted by ultrasonication. The crude cell extracts were centrifuged at 11 000g for 1 h at 277 K. The target proteins from the clarified cell lysates were loaded onto an Ni-NTA column (Qiagen) equilibrated with buffer A. After washing the column with buffer A containing 20 mM imidazole, bound proteins were eluted with buffer A containing 300 mM imidazole. The eluted fraction was loaded onto a HiTrap Q anionexchange column (Amersham Biosciences) and the bound proteins were eluted using a 0-500 mM linear gradient of NaCl. The 6ÂHis-VHb was removed by incubation with recombinant tobacco etch virus (rTEV) protease (Invitrogen) and passage through an Ni-NTA column. After purification, NTA_MO_A still had a two-residue cloning artifact (Gly His) at its N-terminus. The final yield of the protein was approximately 50 mg per litre of cell culture. The purified protein was dialyzed against 20 mM Tris-HCl pH 7.0 containing 5 mM -mercaptoethanol, concentrated to 20 mg ml À1 and stored at 193 K for use in crystallization trials. The homogeneity of the recombinant NTA_MO_A was assessed by 12% SDS-PAGE and Coomassie Brilliant Blue staining (Fig. 2) .
The molecular weight of the purified protein was analyzed by sizeexclusion chromatography. The purified NTA_MO_A protein was loaded onto a Superdex 75 column equilibrated with 50 mM Tris pH 8.0 and 150 mM NaCl. Size-exclusion chromatography showed the molecular weight of NTA_MO_A to be approximately 100 kDa (data not shown), whereas SDS-PAGE suggested a molecular weight of approximately 47.8 kDa (Fig. 2) , indicating that NTA_MO_A probably exists as a homodimer under physiological conditions.
Crystallization
Crystallization of the purified protein was initially performed with commercially available sparse-matrix screens from Hampton Research and Emerald Biostructures using the sitting-drop vapourdiffusion technique at 295 K. Each experiment consisted of mixing 1 ml protein solution (20 mg ml À1 in 20 mM Tris-HCl pH 7.0 and 5 mM -mercaptoethanol) with 1 ml reservoir solution and then equilibrating it against the reservoir solution. After several steps that improved the crystallization process, crystals appeared in 5-6 d and reached their maximal dimensions of approximately 300 Â 50 Â 50 mm using reservoir solution containing 1.6 M NH 2 SO 4 , 0.1 M NaCl and 0.1 M HEPES pH 7.5 (Fig. 3) . 
X-ray analysis
The crystals were transferred to cryoprotectant solution containing 1.7 M NH 2 SO 4 , 0.1 M NaCl, 0.1 M HEPES pH 7.5 and 25%(v/v) glycerol, fished out with a loop larger than the crystals and flashfrozen by immersion in liquid nitrogen at 100 K. The data were collected to a resolution of 2.5 Å at beamline 4A (MXW), which incorporated a Quantum 210 CCD detector (ADSC, USA), at the Pohang Accelerator Laboratory (PAL, Pohang, Korea). A total of 360 images were collected with an oscillation angle of 1 and an exposure time of 5 s per image. The data were indexed, integrated, and scaled using the HKL-2000 package (Otwinowski & Minor, 1997) . The NTA_MO_A crystals belong to the centred monoclinic space group C2, with unit-cell parameters a = 111.04, b = 98.51, c = 171.61 Å , = 101.94 . Assuming four molecules of NTA_MO_A per asymmetric unit, the crystal volume per unit of protein weight was 2.3 Å 3 Da À1 (Matthews, 1968) , which corresponds to a solvent content of approximately 46.5%. Crystallographic data statistics are summarized in Table 1 .
The structure of NTA_MO_A appears to have been solved by molecular replacement. The B. subtilis Ytnj protein (PDB code 1yw1) with side chains converted to Ala was used as the search model. The identity and similarity of the 1yw1 sequence to NTA_MO_A are 37 and 57%, respectively. MOLREP (Vagin & Teplyakov, 1997 ) located four poly-Ala model molecules in the asymmetric unit, forming two dimers. The resulting solution had a correlation coefficient and R factor of 0.426 and 62.1%, respectively. After rigid-body refinement using REFMAC5 (Murshudov et al., 1997) from the CCP4 suite in the resolution range 40-2.5 Å , R and R free were 45.6 and 54.0%, respectively, with a correlation coefficient of 0.671. The initial electron-density map, which was of good quality with backbones well defined by electron density, allowed us to build a three-dimensional NTA_MO_A model. Crystallographic model building and refinement of the structure to 2.5 Å resolution is in progress. 
